Kim Janda - Net Worth and Insider Trading

Kim Janda Net Worth

The estimated net worth of Kim Janda is at least $45 dollars as of 2024-05-06. Kim Janda is the Director of Sorrento Therapeutics Inc and owns about 3,000 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $45. Details can be seen in Kim Janda's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kim Janda has not made any transactions after 2021-12-27 and currently still holds the listed stock(s).

Transaction Summary of Kim Janda

To

Kim Janda Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kim Janda owns 1 companies in total, including Sorrento Therapeutics Inc (SRNE) .

Click here to see the complete history of Kim Janda’s form 4 insider trades.

Insider Ownership Summary of Kim Janda

Ticker Comapny Transaction Date Type of Owner
SRNE Sorrento Therapeutics Inc 2021-12-27 director

Kim Janda Latest Holdings Summary

Kim Janda currently owns a total of 1 stock. Kim Janda owns 3,000 shares of Sorrento Therapeutics Inc (SRNE) as of December 27, 2021, with a value of $45.

Latest Holdings of Kim Janda

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRNE Sorrento Therapeutics Inc 2021-12-27 3,000 0.02 45

Holding Weightings of Kim Janda


Kim Janda Form 4 Trading Tracker

According to the SEC Form 4 filings, Kim Janda has made a total of 4 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Sorrento Therapeutics Inc is the sale of 3,000 shares on December 27, 2021, which brought Kim Janda around $17,640.

Insider Trading History of Kim Janda

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kim Janda Trading Performance

GuruFocus tracks the stock performance after each of Kim Janda's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kim Janda is -62.75%. GuruFocus also compares Kim Janda's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kim Janda within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kim Janda's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kim Janda

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.96
Relative Return to S&P 500(%) -5.69

Kim Janda Ownership Network

Ownership Network List of Kim Janda

No Data

Ownership Network Relation of Kim Janda


Kim Janda Owned Company Details

What does Sorrento Therapeutics Inc do?

Who are the key executives at Sorrento Therapeutics Inc?

Kim Janda is the director of Sorrento Therapeutics Inc. Other key executives at Sorrento Therapeutics Inc include director & See Remarks Henry Ji , Chief Financial Officer Najjam Asghar , and See Remarks Jerome B Zeldis .

Sorrento Therapeutics Inc (SRNE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Therapeutics Inc (SRNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Therapeutics Inc (SRNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Therapeutics Inc (SRNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sorrento Therapeutics Inc Insider Transactions

No Available Data

Kim Janda Mailing Address

Above is the net worth, insider trading, and ownership report for Kim Janda. You might contact Kim Janda via mailing address: 6042 Cornerstone Ct. West, Suite B, San Diego Ca 92121.

Discussions on Kim Janda

No discussions yet.